Top compounds associated with response to MLXIP


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA VX-680 GDSC1000 pan-cancer AAC 0.2 0.0001
mRNA Lisitinib GDSC1000 pan-cancer AAC 0.13 0.0001
mRNA Doxorubicin gCSI pan-cancer AAC -0.2 0.0001
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.12 0.0002
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA GW843682X GDSC1000 pan-cancer AAC 0.19 0.0002
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.13 0.0002
Download CSV